Myung-Hwan Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Myung-Hwan Kim has a total of 578 co-authors. Here are the top co-authors by number of shared publications:
Sang Soo Lee
University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea (the Republic of)
79 shared publications- Sung Koo Lee
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
71 shared publications - Dong-Wan Seo
College of Pharmacy, Dankook University, Cheonan 31116, Republic of Korea
63 shared publications - Do Hyun Park
Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
53 shared publications Tae Jun Song
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
38 shared publicationsSung Koo Lee
Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-gu, Seoul, 05505, Republic of Korea
26 shared publications
Latest Publications
- Open Access
- 15 June 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 17 (6) , 942-948
Enhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
Hyung Ku Chon, Tae Jun Song, Kyoung-Hoon Yoo, Jun Seong Hwang, Myung-Hwan Kim, Eun Kwang Choi, and Tae Hyeon Kim. Gut and Liver 2023;17:942-8. https://doi.org/10.5009/gnl220378
- 15 June 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 17 (6) , 942-948
Open AccessEnhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
Hyung Ku Chon, Tae Jun Song, Kyoung-Hoon Yoo, Jun Seong Hwang, Myung-Hwan Kim, Eun Kwang Choi, and Tae Hyeon Kim. Gut and Liver 2023;17:942-8. https://doi.org/10.5009/gnl220378
- Open Access
- 6 December 2022
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 17 (4) , 638-646
Long-term Outcomes of Endoscopic Intraductal Radiofrequency Ablation for Ampullary Adenoma with Intraductal Extension after Endoscopic Snare Papillectomy
Sung Hyun Cho, Dongwook Oh, Tae Jun Song, Do Hyun Park, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, and Sang Soo Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl220201
- 6 December 2022
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 17 (4) , 638-646
Open AccessLong-term Outcomes of Endoscopic Intraductal Radiofrequency Ablation for Ampullary Adenoma with Intraductal Extension after Endoscopic Snare Papillectomy
Sung Hyun Cho, Dongwook Oh, Tae Jun Song, Do Hyun Park, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, and Sang Soo Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl220201
- Open Access
- 25 September 2022
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 80 (3) , 107-114
Autoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future
Sung-Hoon Moon and Myung-Hwan Kim. Korean J Gastroenterol 2022;80:107-14. https://doi.org/10.4166/kjg.2022.102
- 25 September 2022
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 80 (3) , 107-114
Open AccessAutoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future
Sung-Hoon Moon and Myung-Hwan Kim. Korean J Gastroenterol 2022;80:107-14. https://doi.org/10.4166/kjg.2022.102
- Open Access
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis
In locally advanced pancreatic cancer (LAPC), stereotactic body radiation therapy (SBRT) has been applied as an alternative to concurrent chemoradiotherapy (CCRT); however, direct comparative evidence between these two modalities is scarce. The aim of this study was to compare the clinical outcomes of SBRT with CCRT for LAPC. We retrospectively reviewed the medical records of patients with LAPC who received SBRT (n = 95) or CCRT (n = 66) with a concurrent 5-FU-based regimen between January 2008 and July 2016. The clinical outcomes of freedom from local progression (FFLP), progression-free survival (PFS), overall survival (OS), and toxicities were analyzed before and after propensity score (PS) matching. After a median follow-up duration of 15.5 months (range, 2.3–64.5), the median OS, PFS, and FFLP of the unmatched patients were 17.3 months, 11 months, and 19.6 months, respectively. After PS matching, there were no significant differences between the SBRT and CCRT groups in terms of the 1-year rates of OS (66.7% vs. 80%, p = 0.455), PFS (40.0% vs. 54.2%, p = 0.123), and FFLP (77.2% and 87.1%, p = 0.691). Our results suggest SBRT could be a feasible alternative to CCRT in treating patients with LAPC.
Open AccessStereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis
In locally advanced pancreatic cancer (LAPC), stereotactic body radiation therapy (SBRT) has been applied as an alternative to concurrent chemoradiotherapy (CCRT); however, direct comparative evidence between these two modalities is scarce. The aim of this study was to compare the clinical outcomes of SBRT with CCRT for LAPC. We retrospectively reviewed the medical records of patients with LAPC who received SBRT (n = 95) or CCRT (n = 66) with a concurrent 5-FU-based regimen between January 2008 and July 2016. The clinical outcomes of freedom from local progression (FFLP), progression-free survival (PFS), overall survival (OS), and toxicities were analyzed before and after propensity score (PS) matching. After a median follow-up duration of 15.5 months (range, 2.3–64.5), the median OS, PFS, and FFLP of the unmatched patients were 17.3 months, 11 months, and 19.6 months, respectively. After PS matching, there were no significant differences between the SBRT and CCRT groups in terms of the 1-year rates of OS (66.7% vs. 80%, p = 0.455), PFS (40.0% vs. 54.2%, p = 0.123), and FFLP (77.2% and 87.1%, p = 0.691). Our results suggest SBRT could be a feasible alternative to CCRT in treating patients with LAPC.
- Open Access
- 31 May 2021
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 25 (2) , 259-264
Indication and surgical techniques of bypass choledochojejunostomy for intractable choledocholithiasis
Shin Hwang, Dong-Hwan Jung, Sung Koo Lee, and Myung-Hwan Kim. Ann Hepatobiliary Pancreat Surg 2021;25:259-64. https://doi.org/10.14701/ahbps.2021.25.2.259
- 31 May 2021
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 25 (2) , 259-264
Open AccessIndication and surgical techniques of bypass choledochojejunostomy for intractable choledocholithiasis
Shin Hwang, Dong-Hwan Jung, Sung Koo Lee, and Myung-Hwan Kim. Ann Hepatobiliary Pancreat Surg 2021;25:259-64. https://doi.org/10.14701/ahbps.2021.25.2.259
- Open Access
- 1 March 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 952
Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study
Background. Radiofrequency ablation (RFA) is a palliative method known for its application in the endoscopic treatment of malignant bile duct obstruction. It may be a useful rescue method for metal stent malfunction caused by tumor ingrowth. This study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct obstruction. Methods: From March 2016 to June 2018, 11 patients with unresectable malignant hilar bile duct stricture with occluded bilateral hilar metal stents due to tumor ingrowth were enrolled. Endoluminal RFA was performed through a novel temperature-controlled catheter at a setting of 7 W power for 120 s with a target temperature of 80 °C via endoscopic retrograde cholangiopancreatography (ERCP). The patients’ demographics, clinical outcomes, and adverse events were investigated. Results: The median age was 64 (interquartile range, 54–72) years. All RFA procedures were successful. Clinical success was achieved in eight patients (72.7%). During the follow-up, eight patients (72.7%) showed stent dysfunction, and the median patency after RFA was 50 days (95% confidence interval (CI): 34–not available (NA)). All stent dysfunctions were successfully managed with ERCP. Ten patients died, and the median overall survival was 289 days (95% CI, 107–NA) from RFA to death. There was one case of mild abdominal pain after the procedure without serious adverse events. Conclusions: As a rescue therapy for occluded bilateral hilar metal stents due to tumor ingrowth, endoluminal RFA seemed to be safe and useful in selected patients.
- 1 March 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 952
Open AccessFeasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study
Background. Radiofrequency ablation (RFA) is a palliative method known for its application in the endoscopic treatment of malignant bile duct obstruction. It may be a useful rescue method for metal stent malfunction caused by tumor ingrowth. This study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct obstruction. Methods: From March 2016 to June 2018, 11 patients with unresectable malignant hilar bile duct stricture with occluded bilateral hilar metal stents due to tumor ingrowth were enrolled. Endoluminal RFA was performed through a novel temperature-controlled catheter at a setting of 7 W power for 120 s with a target temperature of 80 °C via endoscopic retrograde cholangiopancreatography (ERCP). The patients’ demographics, clinical outcomes, and adverse events were investigated. Results: The median age was 64 (interquartile range, 54–72) years. All RFA procedures were successful. Clinical success was achieved in eight patients (72.7%). During the follow-up, eight patients (72.7%) showed stent dysfunction, and the median patency after RFA was 50 days (95% confidence interval (CI): 34–not available (NA)). All stent dysfunctions were successfully managed with ERCP. Ten patients died, and the median overall survival was 289 days (95% CI, 107–NA) from RFA to death. There was one case of mild abdominal pain after the procedure without serious adverse events. Conclusions: As a rescue therapy for occluded bilateral hilar metal stents due to tumor ingrowth, endoluminal RFA seemed to be safe and useful in selected patients.
- Open Access
- 15 November 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (6) , 826-832
Utility of Contrast-Enhanced Harmonic Endoscopic Ultrasound for the Guidance and Monitoring of Endoscopic Radiofrequency Ablation
Jun-Ho Choi, Dong-Wan Seo, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, and Myung-Hwan Kim. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19123
- 15 November 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (6) , 826-832
Open AccessUtility of Contrast-Enhanced Harmonic Endoscopic Ultrasound for the Guidance and Monitoring of Endoscopic Radiofrequency Ablation
Jun-Ho Choi, Dong-Wan Seo, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, and Myung-Hwan Kim. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19123
- Open Access
- 1 April 2020
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 95 (2) , 114-118
Adolescent Type 2 Autoimmune Pancreatitis
There are two forms of autoimmune pancreatitis (AIP). Type 1 is associated with immunoglobulin G4 (IgG4)-related systemic fibro- inflammatory disease, whereas type 2 AIP is localized to the pancreas and not associated with IgG4. The number of children presenting with type 2 AIP has recently increased. Here, we report a case of type 2 AIP in a 16-year-old adolescent who presented with clinical acute pancreatitis and associated pancreatic masses. He was diagnosed with type 2 AIP based on pancreatic biopsy results showing granulocytic epithelial lesions and supportive radiological imaging and steroid responsiveness.
- 1 April 2020
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 95 (2) , 114-118
Open AccessAdolescent Type 2 Autoimmune Pancreatitis
There are two forms of autoimmune pancreatitis (AIP). Type 1 is associated with immunoglobulin G4 (IgG4)-related systemic fibro- inflammatory disease, whereas type 2 AIP is localized to the pancreas and not associated with IgG4. The number of children presenting with type 2 AIP has recently increased. Here, we report a case of type 2 AIP in a 16-year-old adolescent who presented with clinical acute pancreatitis and associated pancreatic masses. He was diagnosed with type 2 AIP based on pancreatic biopsy results showing granulocytic epithelial lesions and supportive radiological imaging and steroid responsiveness.
- Open Access
- 15 March 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (2) , 248-256
Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata
Hyun Woo Lee, Sung Koo Lee, Jae Hyuck Jun, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Dong-Wan Seo, and Myung-Hwan Kim. Gut and Liver 2020;14:248-56. https://doi.org/10.5009/gnl18488
- 15 March 2020
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (2) , 248-256
Open AccessTiming and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata
Hyun Woo Lee, Sung Koo Lee, Jae Hyuck Jun, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Dong-Wan Seo, and Myung-Hwan Kim. Gut and Liver 2020;14:248-56. https://doi.org/10.5009/gnl18488
- Open Access
- 1 February 2020
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 95 (1) , 43-49
Endoscopic Transpapillary Gallbladder Stenting for Acute Cholecystitis in a Patient with Metastatic Pancreatic Cancer
Percutaneous transhepatic gallbladder drainage is an effective treatment for acute cholecystitis in poor surgical candidates. Endoscopic gallbladder drainage procedures, such as endoscopic ultrasound-guided gallbladder drainage, endoscopic gallbladder stenting, and endoscopic naso-gallbladder drainage, have been used as alternative treatments for acute cholecystitis. These procedures are associated with increased patient comfort and physiologic drainage. We report a case of endoscopic gallbladder stenting for acute cholecystitis in a 62-year-old male undergoing chemotherapy for metastatic pancreatic cancer. After endoscopic gallbladder stenting, the patient's acute cholecystitis resolved and he was able to undergo scheduled chemotherapy. The inserted double-pigtail plastic stent will be left in situ permanently. The choice of drainage modality for acute cholecystitis will generally be based on resources, patient preferences, local expertise, and clinical context. (
- 1 February 2020
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 95 (1) , 43-49
Open AccessEndoscopic Transpapillary Gallbladder Stenting for Acute Cholecystitis in a Patient with Metastatic Pancreatic Cancer
Percutaneous transhepatic gallbladder drainage is an effective treatment for acute cholecystitis in poor surgical candidates. Endoscopic gallbladder drainage procedures, such as endoscopic ultrasound-guided gallbladder drainage, endoscopic gallbladder stenting, and endoscopic naso-gallbladder drainage, have been used as alternative treatments for acute cholecystitis. These procedures are associated with increased patient comfort and physiologic drainage. We report a case of endoscopic gallbladder stenting for acute cholecystitis in a 62-year-old male undergoing chemotherapy for metastatic pancreatic cancer. After endoscopic gallbladder stenting, the patient's acute cholecystitis resolved and he was able to undergo scheduled chemotherapy. The inserted double-pigtail plastic stent will be left in situ permanently. The choice of drainage modality for acute cholecystitis will generally be based on resources, patient preferences, local expertise, and clinical context. (